Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QNASL for Seasonal Allergic Rhinitis and Sinus Microbiome
NCT01852513Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Jan 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of beclomethasone dipropionate in seasonal allergic rhinitis (SAR), sponsored by University of Chicago. Started Jan 2013; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01852513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01852513.